Therapy Areas: Hereditary Disorders
23 February 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has acquired an exclusive license from Alexion Pharmaceuticals (NASDAQ: ...
3 February 2021 - - Israel-based clinical stage company BiomX Inc. (NYSE American: PHGE) has released positive results of a first-in-human Phase 1a pharmacokinetic study of BX002, the company said.
3 February 2021 - Gene therapy company Krystal Biotech Inc (NASDAQ:KRYS) on Tuesday announced its plans to launch USD100m common stock in underwritten public offering .The company plans to provide the...
29 January 2021 - - The US Food and Drug Administration has cleared an IND, enabling US-based Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) to proceed with initiating a clinical trial for VX-880, an...
13 January 2021 - - The Cystic Fibrosis Foundation has granted a new award of up to USD 2m to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy t...
5 January 2021 - - US-based clinical-stage messenger RNA medicines company Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) has received allowance of the Investigational New Drug application from th...
Related Headlines